Alcon AG at Morgan Stanley Healthcare Conference Transcript
So thanks for joining us here. My name is David Lewis, medical advisor analyst here at Morgan Stanley. It's my pleasure to have this year, Alcon, and this is the first time Alcon sort of in this iteration has been in front of the Morgan Stanley conference. So we're -- obviously a pleasure to have them. We'll talk about that a little bit. But we have 2 members of management here from Alcon, actually 3 members here actually on stage. We have CEO, Dave Endicott; CFO, Tim Stonesifer; and Karen King as many of you obviously know.
Questions & Answers
David, I want to start actually with kind of a strategic question. This came up in our morning session yesterday about the recent medtech spins. We talk about this a lot. Medtech spins "always work." It's a bit of lore out there. One of the things we've talked about is that medical device spins, medical -- besides pharma, never mix, that this is not a very good marriage. And we think Alcon Novartis
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
